Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma

What is the purpose of this trial?

Treatment of Patients with Newly Diagnosed Standard Risk B-Precursor Acute Lymphoblastic Leukemia (AALL0932) (CIRB)

Participation Guidelines

Ages: 1 year - 30 years

Gender: Both

Children's Oncology Group (The)

Dates: 08/19/2010 - 03/01/2020

Last Updated: 02/22/2018

Study HIC#: 1008007226